Seattle, Washington–(Newsfile Corp. – July 8, 2019) – CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces the publication of an article covering (CSE: BILZ).
Scandinavian Tobacco Group A/S has closed a deal to acquire certain pipe tobacco trademarks and designs from Dunhill Tobacco Company of London Limited, a subsidiary of British American Tobacco p.l.c. Included in the deal are premium pipe tobacco trademarks such as Early Morning Pipe, Nightcap, Royal Yacht and Elizabethan Mixture that were previously sold under the Dunhill brand and carry a solid reputation as well as premium positioning. The price paid is confidential, but immaterial.
LGC CAPITAL (LGC Capital Ltd.) (OTCQB: LGGCF) (“LGC”) announces four new additions to the executive team. LGC Chief Operating Officer, Remy di Meglio, together with both John McMullen and Mazen Haddad, has assembled this team bringing over 90 year’s experience with British American Tobacco and Monsanto to LGC. To lead the team, Mazen Haddad will remain as Co-Chairman and take on the additional role of CEO. John McMullen will assume the role as President and Mark Shinners of Arlington Capital will take on the role of CFO. We would like to thank the outgoing CFO Anthony Samaha for his years of service to LGC helping to grow LGC.
MONTRÉAL, April 03, 2019 (GLOBE NEWSWIRE) — LGC Capital Ltd. (TSXV: LG) (OTCQB: LGGCF) (“LGC”)
LGC Capital Ltd. (TSXV: LG) (OTCQB: LGGCF) (“LGC”)
The judgment in the two Quebec Class Action lawsuits against our
subsidiary, Imperial Tobacco Canada Ltd., has been publicly issued by
the Quebec Court of Appeal in Montreal on 1st March 2019.
Breathtec Biomedical Inc. (CSE: BTH) (CNSX: BTH) (FRANKFURT: BTI) (OTCQB: BTHCF) (the “Company” or “Breathtec”) is pleased to announce that as a result of the strength of the data from its Nash Pharmaceuticals pre-clinical research program, it will be changing its name to Algernon Pharmaceuticals Inc.
Nash Pharmaceuticals Inc., a wholly owned subsidiary of Breathtec Biomedical Inc. (CSE: BTH) (CNSX: BTH) (FRANKFURT: BTI) (OTCQB: BTHCF) (the “Company” or “Nash Pharma”) is pleased to announce that it has been accepted to present its pre-clinical data on its inflammatory bowel disease (“IBD”) research program for both Colitis and Crohn’s disease at the upcoming Digestive Disease Week Annual Conference, held in San Diego, CA on May 18 -21.
British American Tobacco (BAT) is proud to announce that it has been named as a Global Top Employer for the second year running. This accreditation follows BAT being certified as a Top Employer for 2019 in 43 markets – an increase from 2018 – across five regions: Europe, Latin America, Asia-Pacific, Africa and Middle East. BAT is just one of 14 companies to receive Global Top Employer status for 2019.
Staffing 360 Solutions, Inc. (NASDAQ: STAF), a company executing an international buy-integrate-build strategy through the acquisition of staffing organizations in the United States and the United Kingdom, today announced that one of its UK businesses, Clement May, has re-signed British American Tobacco (“BAT”) to provide Resource Process Outsourcing and staffing services.